The deubiquitinase USP11 promotes ovarian cancer chemoresistance by stabilizing BIP

Xiaolin Zhu, Yiping Zhang, Qingyu Luo, Xiaowei Wu, Furong Huang, Tong Shu, Yong Wan, Hongyan Chen*, Zhihua Liu*

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

22 Scopus citations
Original languageEnglish (US)
Article number264
JournalSignal Transduction and Targeted Therapy
Volume6
Issue number1
DOIs
StatePublished - Dec 2021

Funding

This study was supported by funding from the National Key R&D Program of China (2020YFA0803300), the National Natural Science Foundation of China (82030089), the CAMS Innovation Fund for Medical Sciences (2016-I2M-1-001, 2019-I2M-1-003, 2019-I2M-2-004), and the Non-profit Central Research Institute Fund of CAMS (2019PT310027).

ASJC Scopus subject areas

  • Genetics
  • Cancer Research

Cite this